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A new direct colorimetric procedure for uric acid assay in serum or urine is described, utilizing a 3,5-dichloro-2-hydroxybenzene sulfonic acid/4-aminophenazone chromogenic system in the presence of horseradish peroxidase and uricase from Aspergillus flavus. This chromogen system has a high absorptivity, affording useful results with sample/reagent volume ratios as low as 0.025. The procedure is applicable to serum, plasma, or diluted urine. A single working reagent is used; the reaction is complete in less than 15 mm at room temperature.
The red dye formed is measured at 520 nm; a blank sample measurement is not needed. The standard curve for the method is linear for uric acid concentrations up to 1500 jzmol/L. Average analytical recovery of uric acid in human sera and urine exceeded 99%; within-run and between-run precision studies showed Cv's of 1 at 340 nm. An initial reading to be used as sample blank is needed, and this makes the method quite laborious as a manual procedure.
Also, highly purified aldehyde dehydrogenase is not always readily available.
In the Kageyama method (5), the hydrogen peroxide in the presence of catalase (hydrogen-peroxide:hydrogen-peroxide oxidoreductase, EC 1.11.1.6) converts methanol to formaldehyde; this last reacts with ammonium ions and acetylacetone, giving the yellow dye 3,5-diacetyl-1,4-dihydrolutidine, which is measured at 410 nm. This method, although highly reliable, has certain disadvantages in routine use: it requires a sample blank for each specimen and a long incubation time.
In an attempt to find an improved detection system to be coupled to the enzymic oxidation of uric acid, we took into consideration the chromogenic system phenol/4-aminophenazone, which, in the presence of peroxidase (hydrogen-peroxide oxidoreductase, EC 1.11.1.7), is oxidized by hydrogen peroxide to form a red quinoneimine dye. This system has become very popular in clinical chemistry after its application by Trinder (6) to the enzymic determination of glucose. However, there are two big obstacles to the use of this chromogenic system in the determination of serum uric acid:
#{149} low concentration of the analyte in serum: the serum! reagent volume ratio needed for adequate sensitivity is so high as to invite interference from other serum components and so make the method unreliable. #{149} incompatibility between the working pH of horseradish peroxidase and that of uricase of animal origin (most commonly used): this makes it difficult to oxidize uric acid and develop the color in a single step.
The following adjustments provide a simple, reliable method in which the above difficulties were overcome:
#{149} by using a substituted phenol, namely, 3,5-dichloro-2-hydroxybenzenesulfonic acid, which by oxidative coupling with 4-aminophenazone gives a quinoneimine dye with a molar absorptivity about fourfold that of phenol (7). This makes it possible to work with a serum/reagent volume ratio low enough to eliminate interferences for practical purposes. #{149} by using a bacterial uricase with a working pH range materially lower than that of animal uricase, which works without major loss of activity at the pH of maximum horseradish peroxidase activity. Figure 1 shows the sequence of the reactions. 
Materials and Methods

Apparatus
Results
Analytical Variables
Reading wavelength: Maximum absorbance of the reaction product was at 512 nm. We also ran 50 serum blanks, chosen from among the apparently least-desirable specimenssamples showing massive hemolysis, high bilirubin content, and gross turbidity-and we always read the minimum absorbance at 520 nm (Table 1) . This wavelength was accordingly adopted in the final procedure, instead of 512 nm; the loss of sensitivity was less than 3%. Color development rate: An overall control was conducted, both with sera (three different concentrations of uric acid: 245, 586, and 1478 tmol/L) and with the working standard, at 22, 30, and 37 #{176}C. Color development was complete within 15 mm at each of these temperatures.
Color stability: This was studied in four different pools of human sera (normal and abnormal for uric acid), in two pools of human urine (normal and abnormal), and on the working standard.
No important changes of absorbance were detected during 30 mm of observation after the recommended incubation time. Precision: Studies of within-run precision for serum and urine and between-run precision for daily analysis of frozen serum pools for 20 days gave the results shown in Table 2 . 
Interferences:
The possibility that interfering substances in the sample could produce false-negative or false-positive results was taken into account.
Serum samples containing normal concentrations of uric acid and different concentrations of presumed interfering substances were analyzed, as were also uric acid solutions containing known amounts of the more commonly used anticoagulants. No interference was found up to the concentrations shown in Table 3 . The effect of bilirubin was assessed by adding known amounts of the substance to portions of a serum pool of known uric acid content. The test was repeated without ferrocyanide in the working reagent, to assess the usefulness of this product. The results were evaluated in terms of uric acid recovery vs the sample without added bilirubin (Table 4) . No significant interference was found from bilirubin up to 170 gmol/L. The effect of ascorbic acid was assessed by adding known amounts of this compound to portions of serum and pooled specimens of urine of known uric acid content; samples were assayed promptly after the addition of ascorbic acid. The results were evaluated in terms of uric acid recovery vs the sample without added ascorbic acid. No interference from ascorbic acid was detected up to 570 fzmol/L in serum and 5.70 mmol/L in urine.
We also tested ascorbic acid for stability in serum and urine, adding it to serum and urine pools of known uric acid content and assaying the uric acid with a reagent not containing ascorbate oxidase. Ascorbic acid no longer interfered with the uric acid assay 90 mm after its addition to serum; in contrast, it still interfered quite materially in urine assays made as late as 24 h after the addition.
Comparative studies: The method was compared with two other enzymic methods in a different series of samples-all of which, however, had been received with specific requests for uric acid assay. The other methods were: uricase/catalase assay (120 samples) and uricase/ultraviolet assay (120 samples).
As for urine, 50 hospital specimens were assayed by our 
Discussion
We have incorporated the specificity of uricase into a quick, direct colorimetric procedure that is suitable for routine hospital laboratory use. In the optimization of the proposed method, the reaction pH and the concentrations or activities
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of all components were taken into account; optimal conditions were taken to be those affording maximum absorbance within = 120
15 mm, greatest possible color stability, and maximum linearity. The problems encountered in setting up the procedure involved several aspects of the reaction, namely, the simultaneous assaying of uricase and peroxidase, test sensitivity, and competition by some interfering substances with the chromogenic system, reflecting the relative nonspecificity of peroxidase.
The use of uricase from Aspergillus flavus, which shows maximum activity at pH 8.5 and at 30 #{176}C (12) as opposed to pH 9.0 and 37 #{176}C for uricase of animal origin, permitted testing at a neutral pH, optimal for horseradish peroxidase, and at room temperature, with a loss of uricase activity not exceeding 20%. The well-known
Trinder chromogenic system (6) was used in the present work in the modified version of Bahram, utilizing DHBS (7) . This substituted phenol gives rise to a quinoneimine dye with an absorptivity about fourfold that obtained with phenol, affording sufficient sensitivity with a low sample/reagent volume ratio (0.025) and with little or no interference from metabolites, drugs, or anticoagulants. Bilirubin is reported (13) to interfere with the quantitation of hydrogen peroxide in systems including peroxidase, the effect being roughly proportional to its concentration and also dependent on reagent composition. Actually, the mechanism by which bilirubin acts is quite complex and not fully understood. According to Witte et al. (13) , in addition to a positive interference from an overlap in the spectra for bilirubin and Trinder's chromophore, there is also a chemical mechanism that produces a negative interference.
They speculate that the main cause of the chemical subtraction of color could be the consumption of a possible electrophilic 4-aminophenazone intermediate by bilirubin. In our method, the spectral interference was substantially overcome by reading at 520 nm, where absorbance by bilirubin and other pigments or serum turbidity is least ( Ascorbic acid has a depressing action on the Trinder chromogen; this has been imputed both to the subtraction of hydrogen peroxide and to actual chromophore destruction (17) . The substance, however, can easily be oxidized by ascorbate oxidase (18, 19) to dehydroascorbic acid, which does not affect the chromogen system. Under our reaction conditions, with 0.15 U of this enzyme per milliliter of working reagent, an ascorbic acid concentration of 570 mol/L in serum had no effect on uric acid determination.
Ascorbic acid, on the other hand, is rapidly dissipated from blood; after administration of even large doses, reported maximum concentrations in 20) . In addition, ascorbic acid is quite unstable in serum; 90 mm standing at room temperature is enough to eliminate interference with the uric acid assay by 285 tmol of ascorbic acid per liter. In urine, considerably higher amounts of ascorbic acid can be found, and the product is far more stable. Nevertheless, by using the amount of ascorbate oxidase stated above, urinary ascorbic acid concentrations as high as 5.70 mmol/L had no effect on uric acid assay.
As for interference from other substances, including several drugs in common use, we had no trouble with serum assays at concentrations vastly in excess of clinically realistic concentrations in blood (Table 3) , with the possible exceptions of a-methyldopa, L-dopa, 3,4-dihydroxyphenylacetic acid, and gentisic acid, which gave borderline interference only at high or very high doses.
The substances just named, on the other hand, definitely disturbed the color reaction in the urine-as was to be expected, because the concentrations in urine much exceed those in serum. In all these cases the uric acid assays were on the low side.
Clouding during the test was avoided by use of Triton X-100 surfactant, which proved effective at the suggested concentration.
Samples with uncommonly high bilirubin or serum lipid concentrations may assay poorly by the proposed method. In such exceptional cases, a parallel blank run without uricase might be useful.
